These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 5614306

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antianginal effects of pentaerythritol tetranitrate.
    Arce-Gomez E, Aspe y Rosas J, Alcocer Diaz Barreiro L, Diaz Barreiro AL.
    Nouv Presse Med; 1980 Sep 25; 9(34 Suppl):2487-91. PubMed ID: 6775303
    [Abstract] [Full Text] [Related]

  • 27. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A, Lepoutre B, Leuridan B, Croccel L, Giard P.
    J Sci Med Lille; 1972 Feb 25; 90(2):83-9. PubMed ID: 4403207
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Evaluation of the clinical effects of a beta-adrenergic blocking agent: butydrine].
    Bianchi G, Guzalian A, Cerri B.
    Minerva Cardioangiol; 1968 Oct 10; 16(10):982-6. PubMed ID: 5727893
    [No Abstract] [Full Text] [Related]

  • 30. [Coronary therapy with Nitro-Sandolanid].
    Jung A.
    Ther Ggw; 1970 Feb 10; 109(2):237-46. PubMed ID: 5441695
    [No Abstract] [Full Text] [Related]

  • 31. [Nitro-sandolanid in angina pectoris].
    Stieglitz T.
    Med Welt; 1973 Apr 20; 24(16):655-6. PubMed ID: 4756332
    [No Abstract] [Full Text] [Related]

  • 32. [The combination preparation VisanoCor in patients with angina pectoris with special monitoring of urinary catecholamines].
    Hagel H.
    Fortschr Med; 1981 Nov 05; 99(41):1714-7. PubMed ID: 7319440
    [Abstract] [Full Text] [Related]

  • 33. [Comparative study on therapeutic efficacy of 2-benzofuryl-p-chlorophenyl carbinol (Clobenfurol) alone or in association with pentaerythritol tetranitrate].
    Martinelli M, Villecco A.
    Minerva Cardioangiol; 1973 Jan 05; 21(1):60-6. PubMed ID: 4572004
    [No Abstract] [Full Text] [Related]

  • 34. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.
    Dagenais GR, Mason RE, Friesinger GC, Wender C, Ross RS.
    Johns Hopkins Med J; 1969 Dec 05; 125(6):301-11. PubMed ID: 4905736
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacology update: anti-anginal agents.
    Romankiewicz JA.
    J Pract Nurs; 1979 Sep 05; 29(9):11-2. PubMed ID: 112248
    [No Abstract] [Full Text] [Related]

  • 36. [Treatment of angina pectoris with Dilcoran 80].
    Strickler W.
    Landarzt; 1967 Oct 31; 43(30):1485-9. PubMed ID: 5609195
    [No Abstract] [Full Text] [Related]

  • 37. [Treatment of coronary angina. Use of a delayed-action nitrate derivative].
    Giard.
    J Sci Med Lille; 1972 Nov 31; 90(11):407-10. PubMed ID: 4650213
    [No Abstract] [Full Text] [Related]

  • 38. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
    MMW Fortschr Med; 2011 Feb 17; 153(7):44-5. PubMed ID: 21648143
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical considerations on the use of an antispastic-antivagal drug association in the cholecysto-coronary syndrome].
    Cristiano P, Panzitta S, Cuiuli V, Petronio A, Giraldi A.
    Minerva Gastroenterol; 1973 Feb 17; 19(4):259-69. PubMed ID: 4592525
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
    Schaller K.
    Z Arztl Fortbild (Jena); 1970 Jul 17; 64(13):671-3. PubMed ID: 4398819
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.